Osimertinib 80mg tablet is a 3rd-gen EGFR-TKI for NSCLC. It boosts survival, enters the brain, and has fewer side effects. Taken once daily, osimertinib 80mg tablet treats lung and brain tumours. Side effects include skin issues,fatigue, and rare lung/heart problems. Regular monitoring is advised